Article info
Clinical science
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye
- Correspondence to Dr Ido D Fabian, Ocular Oncology Service, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK; didifabian{at}gmail.com
Citation
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye
Online issue publication
January 24, 2018
Article Versions
- Previous version (24 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.